Keliomics
PrivateLast Round
Grant
Jan 8, 2024
Total Funding Raised
$1M
Company Overview
Keliomics operates in Healthcare & Life Sciences and is based in New Orleans, Louisiana. Its latest recorded funding round was a Grant round in January 2024.
Keliomics is a biotechnology company that provides a micro physiological system designed for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keliomics Comparables
Compare Keliomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xilis | 88% | |
| Carcinotech | 81% | |
| Hesperos Inc. | 80% |
For institutional investors. Book with your work email.
Keliomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 8, 2024 | ||||
| Seed | Oct 1, 2023 | ||||
| Angel | May 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Keliomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Ideaship | Angel |
| ONAMI | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2024
Grew 27% QoQ, from 11 to 14 employees.
- Jan 8, 2024
$400K grant from the National Cancer Institute.
For institutional investors. Book with your work email.
Keliomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Keliomics's valuation, stock price, and market status.
Is Keliomics a public or private company?
Keliomics is a private company.
What is the current stock price of Keliomics?
Keliomics is a private company, so its shares have no public market price. Caplight tracks Keliomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Keliomics worth (valuation)?
Valuation information for Keliomics is not publicly available.
Can I buy Keliomics stock?
Keliomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Keliomics's last funding round?
Keliomics's most recent funding round was Grant on January 8, 2024.
Who are the main investors in Keliomics?
Key investors in Keliomics include National Cancer Institute, Ideaship, ONAMI.
Will Keliomics IPO soon?
No public IPO plans have been announced for Keliomics.
How can I track Keliomics secondary market activity?
Caplight tracks bids, offers, and trades in Keliomics's shares on secondary markets.